Ledipasvir / sofosbuvir — Tablet (IR, oral)

المنتج المرجعي للتكافؤ الحيوي · Ledipasvir / sofosbuvir

MoleculeLedipasvir / sofosbuvir
Dosage formTablet (IR, oral)
Reference comparatorHarvoni (Gilead)
TierA
Recommended BE approachIn vivo bioequivalence (PK; single-dose fasting, fed if required) — ICH M13A
Illustrative harmonised register entry for the Arab markets. Confirm the definitive comparator with the authority of each market before use.
سجل استرشادي موحد · يلزم تأكيد المقارن النهائي من سلطة كل سوق قبل الاستخدام.

Search the interactive Register (375 entries) · the full table · how to cite

Share: LinkedIn · X · WhatsApp · Telegram · Email

Cite as: AUPAM Experts' Office, Ledipasvir / sofosbuvir (Tablet (IR, oral)) — bioequivalence reference product — AUPAM Register, retrieved 2026-08-31, https://aupameo.org/datasets/register/ledipasvir-sofosbuvir-s215.html